Mental Health Research Accelerator Act of 2025

Bill 119 HR 2085, also known as the Translational Research for Neurodegenerative Diseases and Psychiatric Conditions Act, aims to amend the Internal Revenue Code of 1986 to offer a tax credit for expenses related to translational research in the field of neurodegenerative diseases and psychiatric conditions.

The bill seeks to incentivize and support research efforts focused on finding treatments and cures for diseases such as Alzheimer's, Parkinson's, and mental health conditions like depression and schizophrenia. By providing a tax credit for qualifying expenses incurred during translational research, the legislation aims to encourage more investment and innovation in these critical areas of healthcare.

Overall, Bill 119 HR 2085 aims to promote advancements in the understanding and treatment of neurodegenerative diseases and psychiatric conditions by providing financial support to researchers and organizations engaged in translational research. This bipartisan effort underscores the importance of addressing these pressing health challenges and underscores the role of government in supporting scientific progress and innovation in the medical field.